Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation (Q34163525)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation |
scientific article |
Statements
1 reference
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation (English)
1 reference
Shanna A Arnold
1 reference
Lee B Rivera
1 reference
Juliet G Carbon
1 reference
Jason E Toombs
1 reference
Chi-Lun Chang
1 reference
Amy D Bradshaw
1 reference
Rolf A Brekken
1 reference
14 February 2012
1 reference
1 reference
e31384
1 reference
14 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference